Chromosomal instability of circulating tumor DNA reflect therapeutic responses in advanced gastric cancer

MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer

(2018) Hao Liu et al.   BMC CANCER

HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer

(2018) Haixing Wang et al.   EUROPEAN JOURNAL OF CANCER

Determinants and clinical implications of chromosomal instability in cancer

(2018) Laurent Sansregret et al.   Nature Reviews Clinical Oncology

A proteomic landscape of diffuse-type gastric cancer

(2018) Sai Ge et al.   Nature Communications

Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer

(2018) De-Shen Wang et al.   GUT

Gastric Cancer Etiology and Management in Asia and the West

(2018) Ashley E. Russo et al.   Annual Review of Medicine

Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy

(2018) Dominiek Smeets et al.   Nature Communications

The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples

(2017) Signe Penner-Goeke et al.   PLoS Genetics

Chromosomal Instability in Gastric Cancer Biology

(2017) Saffiyeh Saboor Maleki et al.   NEOPLASIA

Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer

(2017) Laura Thompson et al.   Cancers

Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR

(2016) Atsuko Ashida et al.   International Journal of Clinical Oncology

Clinical impact of tumour biology in the management of gastroesophageal cancer

(2016) Florian Lordick et al.   Nature Reviews Clinical Oncology

Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition

(2016) Jan A. Burger et al.   Nature Communications

Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy

(2016) Weiguo Zhang et al.   Nature Communications

Biomarkers for personalized medicine in GI cancers

(2015) Shuang Yin Zhang et al.   MOLECULAR ASPECTS OF MEDICINE

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

(2015) Kenneth S Thress et al.   NATURE MEDICINE

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

(2015) Razvan Cristescu et al.   NATURE MEDICINE

Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

(2014) G. R. Oxnard et al.   CLINICAL CANCER RESEARCH

Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer

(2014) E. Schutz et al.   CLINICAL CHEMISTRY

Comprehensive molecular characterization of gastric adenocarcinoma

(2014) Adam J. Bass et al.   NATURE

Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer

(2014) Kai Wang et al.   NATURE GENETICS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER